Pfizer Inc. (PFE)
NYSE • Healthcare
November 18, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Pfizer Inc. keeps $20 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 2
in 75 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Pfizer beat expectations on both the top and bottom line in the third fiscal quarter of 2026, reported November 3, 2026, as revenue of $16.583 billion topped the $15.852 billion estimate, +4.6%, even as revenue slipped 0.4% year over year from $16.654 billion. Adjusted EPS of $0.87 topped the $0.73 estimate, +18%, and was essentially flat versus $0.87 a year ago, while net income fell 8.4% year over year to roughly $3.2 billion from $3.541 billion. Profitability held with a gross margin of about 76% and operating margin near 22%, translating into operating income of roughly $3.7 billion alongside gross profit of about $12.6 billion. The quarter generated operating cash flow of about $5.4 billion, and Pfizer paid roughly $2.5 billion in dividends. For the next period, consensus calls for EPS of $0.72 on revenue of $17.064 billion.
About Pfizer Inc.
Pfizer Inc. develops, makes, and sells prescription medicines and vaccines worldwide. Listed on the NYSE as PFE, the company operates in the pharmaceutical business and generated $62.6 billion of revenue in FY2025. Its portfolio spans branded therapies, biosimilars, hospital injectables, and vaccines used across a wide range of treatment and prevention settings.
Today's Snapshot
PFE closed 1.4% lower at 28.06, in line with a weaker sector. Pfizer struck a deal with Starna, a cell-therapy company, to develop treatments given inside the body.
Trading Volume
Above 10d avg 35.9M
37.2M
vs S&P 500 Today
Underperforming Market
-1.18%
Updated: November 18, 2026 at 21:17 UTC
PFE Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$27.27 - $29.19Sell
- RSI (14)37.40Neutral
- Stochastic %K (14, 3, 3)5.55Buy
- MACD Level (12, 26)-0.13Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.